• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一步克隆筛选法:一种开发和研究高滴度病毒载体生产细胞的新工具。

Single-step cloning-screening method: a new tool for developing and studying high-titer viral vector producer cells.

机构信息

Instituto de Biologia Experimental e Tecnológica (iBET), Oeiras, Portugal.

Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal.

出版信息

Gene Ther. 2015 Sep;22(9):685-95. doi: 10.1038/gt.2015.44. Epub 2015 May 4.

DOI:10.1038/gt.2015.44
PMID:25938191
Abstract

This article describes a novel method merging the cloning of viral vector producer cells with vector titer screening, allowing for screening 200-500 clones in 2 weeks. It makes use of a GFP separated into two fragments, S10 and S11 (Split GFP), fluorescing only upon transcomplementation. Producer cells carrying a S11 viral transgene are cloned in 96-well plates and co-cultured with target cells stably expressing S10. During the period of clone expansion, S11 viruses infect S10 target cells reconstituting the GFP signal. Transcomplemented fluorescence data provide direct estimation of the clone's productivity and can be analyzed in terms of density distribution, offering valuable information on the average productivity of the cell population and allowing the identification of high-producing clones. The method was validated by establishing a retrovirus producer from a nude cell line, in <3 months, inserting three vector constructs without clone selection or screening in between. Clones producing up to 10(8) infectious particles per ml were obtained, delivering optimal ratios of infectious-to-total particles (1 to 5). The method was additionally used to evaluate the production performance of HEK 293 and HEK 293T cell lines demonstrating that the latter sustains increased titers. Finally, it was used to study genetic manipulation of glutathione metabolism in retrovirus production showing that changing cell metabolism steers higher vector expression with titer increases of more than one order of magnitude.This method is a valuable tool not only for cell line development but also for genetic manipulation of viral vector and/or producer cells contributing to advancing the field of viral gene therapy.

摘要

本文描述了一种新的方法,将病毒载体生产细胞的克隆与载体滴度筛选相结合,可在 2 周内筛选 200-500 个克隆。它利用 GFP 分成两个片段 S10 和 S11(Split GFP),只有在转互补时才会发光。携带 S11 病毒转基因的生产细胞在 96 孔板中克隆,并与稳定表达 S10 的靶细胞共培养。在克隆扩增期间,S11 病毒感染 S10 靶细胞,重新构成 GFP 信号。转互补荧光数据可直接估计克隆的生产力,并可根据密度分布进行分析,提供有关细胞群体平均生产力的有价值信息,并允许鉴定高产克隆。该方法通过在<3 个月内从裸细胞系建立逆转录病毒生产细胞,在中间无需进行克隆选择或筛选,插入了三个载体构建体进行了验证。获得了高达 10(8)个/ml 的感染性颗粒的克隆,提供了最佳的感染性与总颗粒比(1 比 5)。该方法还用于评估 HEK 293 和 HEK 293T 细胞系的生产性能,表明后者可维持更高的滴度。最后,它被用于研究逆转录病毒生产中谷胱甘肽代谢的遗传操作,表明改变细胞代谢可引导更高的载体表达,滴度增加超过一个数量级。该方法不仅是细胞系开发的有价值工具,也是病毒载体和/或生产细胞遗传操作的有价值工具,有助于推进病毒基因治疗领域。

相似文献

1
Single-step cloning-screening method: a new tool for developing and studying high-titer viral vector producer cells.一步克隆筛选法:一种开发和研究高滴度病毒载体生产细胞的新工具。
Gene Ther. 2015 Sep;22(9):685-95. doi: 10.1038/gt.2015.44. Epub 2015 May 4.
2
An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.一种用于为缺乏选择标记基因的载体生成逆转录病毒生产克隆的改进方法。
Blood Cells Mol Dis. 1998 Jun;24(2):167-82. doi: 10.1006/bcmd.1998.0184.
3
Disclosing the Parameters Leading to High Productivity of Retroviral Producer Cells Lines: Evaluating Random Versus Targeted Integration.揭示逆转录病毒生产细胞系高生产力的参数:评估随机整合与靶向整合
Hum Gene Ther Methods. 2017 Apr;28(2):78-90. doi: 10.1089/hgtb.2016.149.
4
Simplified generation of high-titer retrovirus producer cells for clinically relevant retroviral vectors by reversible inclusion of a lox-P-flanked marker gene.通过可逆性包含lox-P侧翼标记基因,简化用于临床相关逆转录病毒载体的高滴度逆转录病毒生产细胞的生成。
Mol Ther. 2004 May;9(5):738-46. doi: 10.1016/j.ymthe.2004.02.010.
5
The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange.逆转录病毒载体生产细胞系中重组酶介导的盒式交换:通过转基因交换实现的可预测性和效率
J Biotechnol. 2006 Jul 13;124(2):457-68. doi: 10.1016/j.jbiotec.2006.01.037. Epub 2006 Mar 9.
6
Reliable generation of stable high titer producer cell lines for gene therapy.用于基因治疗的稳定高滴度生产细胞系的可靠生成。
Intervirology. 2007;50(3):197-203. doi: 10.1159/000099218. Epub 2007 Feb 2.
7
Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.大规模生产用于免疫治疗方案的安全高效逆转录病毒包装细胞系。
J Gene Med. 1999 May-Jun;1(3):195-209. doi: 10.1002/(SICI)1521-2254(199905/06)1:3<195::AID-JGM31>3.0.CO;2-#.
8
Impact of retroviral vector components stoichiometry on packaging cell lines: effects on productivity and vector quality.逆转录病毒载体成分化学计量对包装细胞系的影响:对生产力和载体质量的作用
Hum Gene Ther. 2008 Feb;19(2):199-210. doi: 10.1089/hum.2007.0101.
9
Rapid screening for high-titer retroviral packaging cell lines using an in situ fluorescence assay.使用原位荧光测定法对高滴度逆转录病毒包装细胞系进行快速筛选。
Hum Gene Ther. 2002 Jun 10;13(9):1005-13. doi: 10.1089/104303402753812412.
10
Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.用于简化生成编码T细胞受体的逆转录病毒载体颗粒的悬浮包装细胞系。
Gene Ther. 2007 Apr;14(7):595-603. doi: 10.1038/sj.gt.3302906. Epub 2007 Jan 18.

引用本文的文献

1
Novel scFv against Notch Ligand JAG1 Suitable for Development of Cell Therapies toward JAG1-Positive Tumors.新型针对 Notch 配体 JAG1 的 scFv 适合开发针对 JAG1 阳性肿瘤的细胞疗法。
Biomolecules. 2023 Mar 2;13(3):459. doi: 10.3390/biom13030459.
2
Lentiviral Vector Bioprocessing.慢病毒载体生物工艺。
Viruses. 2021 Feb 9;13(2):268. doi: 10.3390/v13020268.
3
Evaluation of Structurally Distorted Split GFP Fluorescent Sensors for Cell-Based Detection of Viral Proteolytic Activity.用于基于细胞的病毒蛋白水解活性检测的结构扭曲分裂 GFP 荧光传感器的评估。

本文引用的文献

1
Cellular targets for improved manufacturing of virus-based biopharmaceuticals in animal cells.用于提高动物细胞中基于病毒的生物制药生产的细胞靶标。
Trends Biotechnol. 2014 Dec;32(12):602-7. doi: 10.1016/j.tibtech.2014.09.010. Epub 2014 Oct 28.
2
HEK293-based production platform for γ-retroviral (self-inactivating) vectors: application for safe and efficient transfer of COL7A1 cDNA.基于人胚肾293细胞的γ-逆转录病毒(自失活)载体生产平台:用于安全高效转移Ⅶ型胶原蛋白α1链(COL7A1)互补DNA的应用
Hum Gene Ther Clin Dev. 2014 Dec;25(4):218-28. doi: 10.1089/humc.2014.083.
3
Metabolic pathways recruited in the production of a recombinant enveloped virus: mining targets for process and cell engineering.
Sensors (Basel). 2020 Dec 23;21(1):24. doi: 10.3390/s21010024.
4
LentiPro26: novel stable cell lines for constitutive lentiviral vector production.LentiPro26:用于组成型慢病毒载体生产的新型稳定细胞系。
Sci Rep. 2018 Mar 27;8(1):5271. doi: 10.1038/s41598-018-23593-y.
5
Gene Therapy.基因治疗
Adv Biochem Eng Biotechnol. 2018;165:351-399. doi: 10.1007/10_2016_53.
用于重组包膜病毒生产的代谢途径:挖掘过程和细胞工程的目标。
Metab Eng. 2013 Nov;20:131-45. doi: 10.1016/j.ymben.2013.10.001. Epub 2013 Oct 11.
4
RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy.RD2-MolPack-Chim3,一种用于抗HIV基因治疗的慢病毒载体稳定生产的包装细胞系。
Hum Gene Ther Methods. 2013 Aug;24(4):228-40. doi: 10.1089/hgtb.2012.190. Epub 2013 Aug 3.
5
First gene therapy nears landmark European market authorization.首款基因疗法临近具有里程碑意义的欧洲市场授权。
Nat Biotechnol. 2012 Sep;30(9):807-9. doi: 10.1038/nbt0912-807.
6
Gene therapy matures in the clinic.基因疗法在临床中逐渐成熟。
Nat Biotechnol. 2012 Jul 10;30(7):588-93. doi: 10.1038/nbt.2290.
7
Rapid titration of retroviral vectors using a β-lactamase protein fragment complementation assay.利用β-内酰胺酶蛋白片段互补测定法快速滴定逆转录病毒载体。
Gene Ther. 2013 Jan;20(1):43-50. doi: 10.1038/gt.2011.212. Epub 2012 Jan 19.
8
Adaptation of retrovirus producer cells to serum deprivation: Implications in lipid biosynthesis and vector production.逆转录病毒生产细胞对血清饥饿的适应:对脂质生物合成和载体生产的影响。
Biotechnol Bioeng. 2012 May;109(5):1269-79. doi: 10.1002/bit.24410. Epub 2012 Jan 2.
9
Lentivirus production is influenced by SV40 large T-antigen and chromosomal integration of the vector in HEK293 cells.慢病毒的生产受 SV40 大 T 抗原和载体在 HEK293 细胞中的染色体整合的影响。
Hum Gene Ther. 2011 Oct;22(10):1269-79. doi: 10.1089/hum.2010.143. Epub 2011 Jun 13.
10
Gene therapy finds its niche.基因治疗找到了自己的定位。
Nat Biotechnol. 2011 Feb;29(2):121-8. doi: 10.1038/nbt.1769.